Children's Hospital, Helsinki University Central Hospital, University of Helsinki, FI-00029 Helsinki, Finland.
Mol Cell Endocrinol. 2011 Jul 20;341(1-2):35-8. doi: 10.1016/j.mce.2011.05.015. Epub 2011 Jun 1.
Mutations in FGFR1, GNRHR, PROK2, PROKR2, TAC3, or TACR3 underlie isolated hypogonadotropic hypogonadism (IHH) with clinically variable phenotypes, and, by causing incomplete intrauterine activation of the hypothalamic-pituitary-gonadal axis, may lead to cryptorchidism. To investigate the role of defects in these genes in the etiology of isolated cryptorchidism, we screened coding exons and exon-intron boundaries of these genes in 54 boys or men from 46 families with a history of cryptorchidism. Control subjects (200) included 120 males. None of the patients carried mutation(s) in FGFR1, PROK2, PROKR2, TAC3 or TACR3. Two of the 46 index subjects with unilateral cryptorchidism were heterozygous carriers of a single GNRHR mutation (Q106R or R262Q), also present in male controls with a similar frequency (3/120; p=0.62). No homozygous or compound heterozygous GNRHR mutations were found. In conclusion, cryptorchidism is not commonly caused by defects in genes involved in IHH.
FGFR1、GNRHR、PROK2、PROKR2、TAC3 或 TACR3 的突变导致孤立性促性腺激素低下性性腺功能减退症(IHH),其临床表现具有临床变异性,并且由于不完全激活下丘脑-垂体-性腺轴的宫内激活,可能导致隐睾。为了研究这些基因缺陷在孤立性隐睾症发病机制中的作用,我们对 46 个有隐睾症家族史的男孩或成年男性的 54 名进行了 FGFR1、GNRHR、PROK2、PROKR2、TAC3 或 TACR3 这些基因的编码外显子和外显子-内含子边界的筛查。对照组(200 名)包括 120 名男性。在 FGFR1、PROK2、PROKR2、TAC3 或 TACR3 中,没有患者携带突变。46 名单侧隐睾症患者中有 2 名为 GNRHR 突变(Q106R 或 R262Q)的杂合子携带者,在具有相似频率的男性对照中也存在相同的突变(3/120;p=0.62)。未发现纯合子或复合杂合子 GNRHR 突变。总之,隐睾症不是由参与 IHH 的基因缺陷引起的。